Our objective was to investigate the potential of three microRNAs, miR-181a-5p, miR-30c-
5p, and miR-206 as prognostic biomarkers for long-term follow up of Duchenne muscular …

Circulating microRNAs (miRs/miRNAs) are being used as non-invasive biomarkers for
diagnosis, prognosis and efficiency of clinical trials. However, to exploit their potential it is …

Becker muscular dystrophy (BMD) is an X‐linked neuromuscular disorder due to mutation in
the DMD gene, encoding dystrophin. Despite a wide clinical variability, BMD is …

Creatine kinase has been utilized as a diagnostic marker for Duchenne muscular dystrophy
(DMD), but it correlates less well with the DMD pathological progression. In this study, we …

Noninvasive biomarkers with diagnostic value and prognostic applications have long been
desired to replace muscle biopsy for Duchenne muscular dystrophy (DMD) patients …

Abstract Objective The diagnosis of Duchenne Muscular Dystrophy (DMD) currently
depends on non-specific measures such as Creatine kinase (CK) levels. MicroRNAs …

Background: Duchenne Muscular Dystrophy (DMD) is a recessive X-linked form of muscular
dystrophy. Steroid therapy has clinical benefits for DMD patients, but the mechanism …

The amount and distribution of dystrophin protein in myofibers and muscle is highly variable
in Becker muscular dystrophy and in exon-skipping trials for Duchenne muscular dystrophy …

Duchenne Muscular Dystrophy (DMD) is an X-linked neuromuscular disorder in which the
detection of female carriers is of the utmost importance for genetic counseling. Haplotyping …

Creatine kinase (CK) as a biomarker has long been expected to be replaced by other fluid
biomarkers for Duchenne muscular dystrophy (DMD) because it is independent of disease …